Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Meredith Cummings on Using Machine Learning to Predict Treatment-Related Adverse Events

      June 9, 2023
      By Meredith Cummings BSN, RN, OCN
      Video
      Conferences|ONS Annual Congress

      Meredith Cummings BSN, RN, OCN, highlights her research on machine learning and its potential application in optimizing symptom management.

      Machine learning may have a growing role in predicting adverse events in patients undergoing cancer therapy, according to Meredith Cummings BSN, RN, OCN.

      Cummings, who is a PhD student at the University of Pittsburgh School of Nursing, and who works in an outpatient infusion center with Allegheny Health Network Cancer Institute, recently presented on machine learning in a poster presentation, at the 48th Annual Oncology Nursing Society Congress.

      The purpose of the review was to characterize the state of machine learning use in predicting treatment-related symptoms. The review was also designed to identify the gaps related to machine learning predictive models.

      Investigators conducted their review in accordance with the Preferred Reporting for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines. They used PubMed to search for articles and selected those that evaluated machine learning to predict anticancer therapy symptoms for patients with head and neck cancer. Their initial search found 331 articles. After the abstracts were screened for eligibility, a total of 30 articles were evaluated.

      Ultimately, a large proportion of articles included all patients with head and neck cancers (n = 11). Nine studies included patients with esophageal and nasopharyngeal cancers and 1 included patients with laryngeal cancer. The most explored treatment modality was radiation (62%). Of note, only 3 studies included external validation measures to assess the predictive models. In the synthesis of these studies, the most commonly predictive symptoms included radiation-induced xerostomia, radiation induced temporal lobe injury, and chemotherapy-induced myelosuppression. These models were able to predict treatment-related symptoms with an area under the curve (AUC) accuracy range of 0.65 to 0.85.

      According to Cummings, machine learning may prove a useful tool to optimize symptom management in this patient population. She encourages nurses to familiarize themselves with machine learning and its potentially predictive capabilities.

      Reference

      Cummings M, Nilsen M, Bender C, Al-Zaiti S. Predicting anti-cancer treatment-related symptoms in patients with head and neck cancer using a machine learning approach: a scoping review. Poster presented at: 48th Annual Oncology Nursing Society Congress; April 26-30, 2023; San Antonio, TX. Accessed May 25, 2023. https://ons.confex.com/ons/2023/meetingapp.cgi/Paper/13510

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
      Photo of a man wearing a suit with a blue tie in front of a dark blue background
      4 experts in this video
      4 experts in this video
      Photo of a man wearing glasses and a suit in front of a blue background
      Related Content

      Graphic of a person with tumors in their right lung

      ZEN-3694 Receives FDA Fast Track Status in Metastatic NUT Carcinoma

      Russ Conroy
      July 23rd 2025
      Article

      The investigational BET inhibitor is being investigated combined with abemaciclib or cisplatin/etoposide in NUT carcinoma in 2 clinical trials.


      Heather Santone Talks Barriers to Cancer Care in Older Populations

      Heather Santone Talks Barriers to Cancer Care in Older Populations

      Lindsay Fischer
      September 13th 2023
      Podcast

      Heather Santone breaks down some of the barriers that geriatric patients with cancer face—and how nurse navigators can help them overcome these obstacles.


      Graphic of a kidney with a tumor

      KIM-1 Biomarker May Be Prognostic of Response, Outcomes in RCC

      Kyle Doherty
      July 21st 2025
      Article

      Levels of kidney injuring molecule–1 appear to be predictive of therapeutic benefit in patients with renal cell carcinoma.


       Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

      Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

      Lindsay Fischer
      September 1st 2023
      Podcast

      Shawna Douglas, BSN, RN, discusses the role that nurse navigators play in caring for patients with head and neck cancer.


      Graphic of a breast with a tumor

      Real-World Data Tie Early Breast Cancer ctDNA to Recurrence, Lower OS

      Jax DiEugenio
      July 14th 2025
      Article

      Data from a research database link ctDNA positivity in early breast cancer with poorer survival and higher recurrence risk.


      Image of a laptop with the words "FDA Food and Drug Adminstration" visible

      Oncology Drugs Approved by the FDA in June

      Bridget Hoyt
      July 2nd 2025
      Article

      Oncologic therapies approved in June included indications in genitourinary, lung, hematologic, and head and neck cancers.

      Related Content

      Graphic of a person with tumors in their right lung

      ZEN-3694 Receives FDA Fast Track Status in Metastatic NUT Carcinoma

      Russ Conroy
      July 23rd 2025
      Article

      The investigational BET inhibitor is being investigated combined with abemaciclib or cisplatin/etoposide in NUT carcinoma in 2 clinical trials.


      Heather Santone Talks Barriers to Cancer Care in Older Populations

      Heather Santone Talks Barriers to Cancer Care in Older Populations

      Lindsay Fischer
      September 13th 2023
      Podcast

      Heather Santone breaks down some of the barriers that geriatric patients with cancer face—and how nurse navigators can help them overcome these obstacles.


      Graphic of a kidney with a tumor

      KIM-1 Biomarker May Be Prognostic of Response, Outcomes in RCC

      Kyle Doherty
      July 21st 2025
      Article

      Levels of kidney injuring molecule–1 appear to be predictive of therapeutic benefit in patients with renal cell carcinoma.


       Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

      Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

      Lindsay Fischer
      September 1st 2023
      Podcast

      Shawna Douglas, BSN, RN, discusses the role that nurse navigators play in caring for patients with head and neck cancer.


      Graphic of a breast with a tumor

      Real-World Data Tie Early Breast Cancer ctDNA to Recurrence, Lower OS

      Jax DiEugenio
      July 14th 2025
      Article

      Data from a research database link ctDNA positivity in early breast cancer with poorer survival and higher recurrence risk.


      Image of a laptop with the words "FDA Food and Drug Adminstration" visible

      Oncology Drugs Approved by the FDA in June

      Bridget Hoyt
      July 2nd 2025
      Article

      Oncologic therapies approved in June included indications in genitourinary, lung, hematologic, and head and neck cancers.

      Latest Conference Coverage

      Understanding How On-Target and Off-Target ADC Toxicities Work

      Monitoring for Infection-Like AEs Is Essential for CIML NK in GI Cancers

      Belzutifan May Lengthen Quality-Adjusted Survival in Advanced RCC

      KIM-1 Biomarker May Be Prognostic of Response, Outcomes in RCC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.